BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 28994388)

  • 1. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Guffroy A; Martin T; Gies V
    Rev Med Interne; 2020 Oct; 41(10):649-652. PubMed ID: 32768267
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision oncology: where next?
    Gore M; Larkin J
    Lancet Oncol; 2015 Dec; 16(16):1593-5. PubMed ID: 26678189
    [No Abstract]   [Full Text] [Related]  

  • 4. Moving Molecular Profiling to Routine Clinical Practice: A Way Forward?
    Freidlin B; Allegra CJ; Korn EL
    J Natl Cancer Inst; 2020 Aug; 112(8):773-778. PubMed ID: 31868907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric oncology enters an era of precision medicine.
    Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW
    Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Medicine Takes the Stage, Again!
    Tempero M
    J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
    [No Abstract]   [Full Text] [Related]  

  • 7. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer molecular markers: A guide to cancer detection and management.
    Nair M; Sandhu SS; Sharma AK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):39-55. PubMed ID: 29428478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer diagnostics: The journey from histomorphology to molecular profiling.
    Ahmed AA; Abedalthagafi M
    Oncotarget; 2016 Sep; 7(36):58696-58708. PubMed ID: 27509178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision oncology: Charting a path forward to broader deployment of genomic profiling.
    Schram AM; Berger MF; Hyman DM
    PLoS Med; 2017 Feb; 14(2):e1002242. PubMed ID: 28222135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 15. Personalized medicine in cancer: where are we today?
    Turnbull AK
    Future Oncol; 2015; 11(20):2795-8. PubMed ID: 26344657
    [No Abstract]   [Full Text] [Related]  

  • 16. Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic?
    Tripathy D; Harnden K; Blackwell K; Robson M
    BMC Med; 2014 Aug; 12():140. PubMed ID: 25286031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decision support framework for genomically informed investigational cancer therapy.
    Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
    Saumet A; Lecellier CH
    Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.
    Lin VTG; Yang ES
    J Natl Cancer Inst; 2019 Oct; 111(10):1016-1022. PubMed ID: 31165154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.